Biomarker testing in lung cancer patients has increased in real-world clinical practi

[News]

More than half of patients diagnosed with advanced non-small cell lung cancer (NSCLC) undergo biomarker testing, and this figure has increased over the last five years, reveal real-world data from a Spanish national registry study reported at the European Lung Cancer Congress, 30 March-2 April 2022.

More... (https://www.news-medical.net/news/20220323/Biomarker-testing-in-lung-cancer-patients-has-increased-in-real-world-clinical-practice-study-reveals.aspx)